PMO Interview with the Innovator Series: Volume 2

Peter Hirth, PhD

Video Categories: PMO Interview with the Innovator Series

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.
October 16, 2015

Hot Topics in Treating Cutaneous Malignancies

Dr. Sanjiv Agarwala identifies the newest developments in treatments for melanoma, cutaneous T-cell lymphoma, Merkel cell carcinoma, squamous-cell carcinoma, and invasive-cell carcinoma.

November 24, 2014

Foundation Medicine on a Molecular Level

Dr. Gary Palmer explains how Foundation Medicine is working to improve cancer therapies and personalized medicine on a molecular level.